+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Therapy Manufacturing Market - Global Forecast 2026-2032- Product Image
Cell Therapy Manufacturing Market - Global Forecast 2026-2032- Product Image
New

Cell Therapy Manufacturing Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6280868
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Cell Therapy Manufacturing: Executive Overview

Cell therapy manufacturing encompasses the development, production, testing, storage, and delivery of living-cell products for clinical and commercial use. The field is shaped by stringent quality requirements, specialized facilities, complex supply chains, and the need to preserve cell identity, viability, potency, and traceability across highly variable biological inputs.

Manufacturing Is Shifting Toward More Integrated and Flexible Models

Cell therapy manufacturing is moving from bespoke, manually intensive workflows toward more standardized, closed, and digitally connected processes. Key shifts include increased use of automation, modular cleanroom designs, single-use technologies, process analytical technologies, and decentralized or regional production models. These changes aim to reduce contamination risk, improve reproducibility, shorten handling steps, and support production closer to treatment centers while maintaining regulatory control.

Artificial Intelligence Strengthens Process Control and Decision-Making

Artificial intelligence can support cell therapy manufacturing by analyzing process, imaging, environmental, and quality data. Potential applications include identifying process deviations, optimizing culture conditions, improving release testing, predicting equipment maintenance needs, and strengthening batch documentation. Its practical impact depends on representative datasets, validated algorithms, secure data infrastructure, explainability, and clear human oversight. AI does not replace validated manufacturing procedures or regulatory accountability; it extends the ability of teams to detect patterns and act earlier.

Regional Insights: Capacity, Regulation, and Infrastructure Develop Differently

North America combines advanced cell-processing infrastructure, experienced clinical networks, and established regulatory pathways, while Latin America is focused on building specialized capabilities and improving access to qualified materials, training, and quality systems. Europe benefits from strong scientific institutions and harmonization efforts, although cross-border requirements and capacity coordination remain important considerations. The Middle East is investing in advanced healthcare infrastructure and translational capabilities, whereas Africa’s progress is closely linked to workforce development, reliable utilities, regional partnerships, and locally appropriate manufacturing models. Asia-Pacific presents diverse conditions, ranging from mature biopharmaceutical ecosystems to rapidly developing manufacturing bases, with regulatory alignment, supply-chain resilience, and technology transfer remaining central themes.

Group Insights: Cooperation Shapes Standards and Supply Resilience

ASEAN countries are strengthening regional cooperation while addressing differences in regulatory maturity, infrastructure, and workforce specialization. BRICS members bring substantial scientific, industrial, and healthcare diversity, creating opportunities for technology collaboration alongside challenges in regulatory interoperability and supply continuity. The European Union emphasizes common standards, cross-border quality expectations, and coordinated innovation. G7 economies generally contribute advanced research, regulatory experience, and high-complexity manufacturing capabilities. GCC countries are developing biomedical infrastructure and talent programs, while NATO members can benefit from coordinated resilience planning for critical medicines, specialized materials, data systems, and manufacturing inputs.

Country Insights: National Strengths Require Coordinated Execution

Australia has strong translational research capabilities and a geographically dispersed delivery environment. Brazil and Mexico are expanding advanced-therapy capacity while navigating infrastructure, reimbursement, and specialized workforce requirements. Canada combines research expertise with a collaborative healthcare setting. China, India, Japan, and South Korea have substantial scientific and manufacturing capabilities, with continued emphasis on regulatory refinement, automation, and domestic supply resilience. France, Germany, Italy, Spain, and the United Kingdom contribute established biomedical research, clinical expertise, and quality frameworks, while coordination across jurisdictions remains important. Russia has scientific and industrial capabilities but faces constraints related to international access, supply chains, and collaboration. The United States remains a major center for cell therapy research, clinical translation, regulatory development, and specialized manufacturing expertise.

Action Priorities for Cell Therapy Manufacturing Leaders

Leaders should design manufacturing platforms around product-specific risk while standardizing equipment, data structures, and critical operating procedures wherever possible. Priorities include qualifying multiple sources for essential materials, developing robust chain-of-identity and chain-of-custody controls, investing in closed and automated processing, and linking process data with quality management systems. Organizations should validate AI use cases incrementally, establish clear governance for model changes, and train personnel in both advanced manufacturing and data integrity. Regional capacity planning should also account for utilities, cold-chain performance, skilled labor, regulatory expectations, and continuity of patient access.

Research Methodology: Evidence-Based Executive Synthesis

This executive summary uses the supplied market definition-cell therapy manufacturing-and organizes established industry dynamics into operational, technological, geographic, and strategic themes. The analysis emphasizes verifiable characteristics of cell-based production, including quality control, process standardization, automation, supply-chain management, regulatory oversight, and workforce requirements. It intentionally excludes market estimates, market shares, forecasts, and company-specific claims. Regional, group, and country observations are presented as qualitative synthesis rather than numerical ranking.

Conclusion: Scalable Quality Will Define Manufacturing Progress

The future of cell therapy manufacturing will depend on the ability to combine biological flexibility with disciplined, repeatable execution. Closed processing, automation, digital traceability, resilient sourcing, and appropriately governed artificial intelligence can improve consistency and operational visibility. Success will ultimately require alignment among manufacturers, healthcare providers, regulators, technology developers, and infrastructure partners so that innovation translates into reliable, compliant, and accessible cell-based therapies.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cell Therapy Manufacturing Market, by Therapy Type
7.1. Introduction
7.2. Dendritic Cell Therapies
7.3. NK Cell Therapies
7.4. Stem Cell Therapies
7.4.1. Hematopoietic Stem Cell Therapies
7.4.2. iPSC Derived Therapies
7.4.3. Mesenchymal Stem Cell Therapies
7.5. T Cell Therapies
7.5.1. CAR-T
7.5.2. TCR-T
7.5.3. Tumor Infiltrating Lymphocytes
8. Cell Therapy Manufacturing Market, by Cell Source
8.1. Introduction
8.2. Allogeneic
8.3. Autologous
8.4. Bone Marrow
8.5. iPSC Source
8.6. Peripheral Blood
8.7. Tissue Derived
8.8. Umbilical Cord
9. Cell Therapy Manufacturing Market, by Indication
9.1. Introduction
9.2. Autoimmune Disorders
9.3. Cardiovascular Diseases
9.4. Infectious Diseases
9.5. Neurological Disorders
9.6. Oncology
9.6.1. Hematologic Malignancies
9.6.2. Solid Tumors
9.7. Orthopedic And Regenerative Medicine
10. Cell Therapy Manufacturing Market, by End User
10.1. Introduction
10.2. Academic And Research Institutions
10.3. Contract Research Organizations
10.4. Hospitals And Treatment Centers
10.5. Pharmaceutical And Biotechnology Companies
11. Cell Therapy Manufacturing Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Cell Therapy Manufacturing Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Cell Therapy Manufacturing Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Adaptimmune Therapeutics plc
15.2. AGC Biologics
15.3. Allogene Therapeutics Inc
15.4. Autolus Therapeutics
15.5. BioNTech SE
15.6. Bluebird Bio Inc
15.7. Bristol-Myers Squibb Company
15.8. Catalent Inc
15.9. Cellular Biomedicine Group
15.10. Charles River Laboratories International Inc
15.11. Fujifilm Diosynth Biotechnologies
15.12. Gilead Sciences Inc
15.13. Iovance Biotherapeutics Inc
15.14. Janssen Biotech Inc
15.15. Kite Pharma
15.16. Legend Biotech USA Inc
15.17. Lonza Group AG
15.18. Merck KGaA
15.19. Minaris Advanced Therapies
15.20. Novartis AG
15.21. Oxford Biomedica plc
15.22. Sartorius AG
15.23. Thermo Fisher Scientific Inc
15.24. Vertex Pharmaceuticals Incorporated
15.25. WuXi AppTec
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Cell Therapy Manufacturing Market, Years Considered for the Study
FIGURE 2. Global Cell Therapy Manufacturing Market, Research Design
FIGURE 3. Global Cell Therapy Manufacturing Market, Research Framework
FIGURE 4. Global Cell Therapy Manufacturing Market, Data Triangulation
FIGURE 5. Global Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Cell Therapy Manufacturing Market Size, by Therapy Type, 2025 vs 2032 (%)
FIGURE 7. Global Cell Therapy Manufacturing Market Size, by Therapy Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Cell Therapy Manufacturing Market Size, by Cell Source, 2025 vs 2032 (%)
FIGURE 9. Global Cell Therapy Manufacturing Market Size, by Cell Source, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Cell Therapy Manufacturing Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 11. Global Cell Therapy Manufacturing Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Cell Therapy Manufacturing Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Cell Therapy Manufacturing Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Cell Therapy Manufacturing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Cell Therapy Manufacturing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Cell Therapy Manufacturing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Cell Therapy Manufacturing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Cell Therapy Manufacturing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Cell Therapy Manufacturing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Cell Therapy Manufacturing Market Segmentation & Coverage
TABLE 2. Global Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 4. Global Dendritic Cell Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Dendritic Cell Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Dendritic Cell Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global NK Cell Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global NK Cell Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global NK Cell Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Stem Cell Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Stem Cell Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Stem Cell Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Hematopoietic Stem Cell Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Hematopoietic Stem Cell Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Hematopoietic Stem Cell Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global iPSC Derived Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global iPSC Derived Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global iPSC Derived Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Mesenchymal Stem Cell Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Mesenchymal Stem Cell Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Mesenchymal Stem Cell Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global T Cell Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global T Cell Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global T Cell Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global CAR-T Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global CAR-T Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global CAR-T Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global TCR-T Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global TCR-T Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global TCR-T Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Tumor Infiltrating Lymphocytes Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Tumor Infiltrating Lymphocytes Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Tumor Infiltrating Lymphocytes Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 35. Global Allogeneic Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Allogeneic Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Allogeneic Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Autologous Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Autologous Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Autologous Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Bone Marrow Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Bone Marrow Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Bone Marrow Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global iPSC Source Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global iPSC Source Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global iPSC Source Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Peripheral Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Peripheral Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Peripheral Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Tissue Derived Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Tissue Derived Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Tissue Derived Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Umbilical Cord Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Umbilical Cord Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Umbilical Cord Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 57. Global Autoimmune Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Autoimmune Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Autoimmune Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Cardiovascular Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Cardiovascular Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Cardiovascular Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Neurological Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Neurological Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Neurological Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Hematologic Malignancies Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Hematologic Malignancies Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Hematologic Malignancies Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Solid Tumors Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Solid Tumors Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Solid Tumors Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Orthopedic And Regenerative Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Orthopedic And Regenerative Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Orthopedic And Regenerative Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Global Academic And Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Academic And Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Academic And Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Hospitals And Treatment Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Hospitals And Treatment Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Hospitals And Treatment Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Pharmaceutical And Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Pharmaceutical And Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Pharmaceutical And Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Cell Therapy Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Cell Therapy Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. North America Cell Therapy Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. North America Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 105. North America Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 106. North America Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 107. North America Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 108. North America Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 109. North America Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 110. North America Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Latin America Cell Therapy Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Latin America Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 113. Latin America Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 114. Latin America Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 115. Latin America Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 116. Latin America Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 117. Latin America Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 118. Latin America Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. Europe Cell Therapy Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Europe Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 121. Europe Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 122. Europe Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 123. Europe Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 124. Europe Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 125. Europe Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 126. Europe Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. Middle East Cell Therapy Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Middle East Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 129. Middle East Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 130. Middle East Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 131. Middle East Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 132. Middle East Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 133. Middle East Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 134. Middle East Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. Africa Cell Therapy Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Africa Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 137. Africa Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 138. Africa Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 139. Africa Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 140. Africa Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 141. Africa Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 142. Africa Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. Global Cell Therapy Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. ASEAN Cell Therapy Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. ASEAN Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 146. ASEAN Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 147. ASEAN Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 148. ASEAN Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 149. ASEAN Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 150. ASEAN Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 151. ASEAN Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. GCC Cell Therapy Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. GCC Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 154. GCC Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 155. GCC Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 156. GCC Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 157. GCC Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 158. GCC Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 159. GCC Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. European Union Cell Therapy Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. European Union Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 162. European Union Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 163. European Union Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 164. European Union Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 165. European Union Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 166. European Union Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 167. European Union Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. BRICS Cell Therapy Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. BRICS Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 170. BRICS Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 171. BRICS Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 172. BRICS Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 173. BRICS Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 174. BRICS Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 175. BRICS Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. G7 Cell Therapy Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. G7 Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 178. G7 Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 179. G7 Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 180. G7 Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 181. G7 Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 182. G7 Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 183. G7 Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. NATO Cell Therapy Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. NATO Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 186. NATO Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 187. NATO Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 188. NATO Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 189. NATO Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 190. NATO Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 191. NATO Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. Global Cell Therapy Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 193. United States Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 194. United States Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 195. United States Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 196. United States Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 197. United States Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 198. United States Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 199. United States Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 200. United States Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. Canada Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 202. Canada Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 203. Canada Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 204. Canada Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 205. Canada Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 206. Canada Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 207. Canada Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 208. Canada Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Mexico Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 210. Mexico Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 211. Mexico Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 212. Mexico Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 213. Mexico Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 214. Mexico Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 215. Mexico Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 216. Mexico Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. Brazil Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 218. Brazil Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 219. Brazil Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 220. Brazil Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 221. Brazil Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 222. Brazil Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 223. Brazil Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 224. Brazil Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. United Kingdom Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 226. United Kingdom Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 227. United Kingdom Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 228. United Kingdom Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 229. United Kingdom Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 230. United Kingdom Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 231. United Kingdom Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 232. United Kingdom Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. Germany Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 234. Germany Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 235. Germany Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 236. Germany Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 237. Germany Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 238. Germany Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 239. Germany Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 240. Germany Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. France Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 242. France Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 243. France Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 244. France Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 245. France Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 246. France Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 247. France Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 248. France Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Russia Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 250. Russia Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 251. Russia Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 252. Russia Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 253. Russia Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 254. Russia Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 255. Russia Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 256. Russia Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. Italy Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 258. Italy Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 259. Italy Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 260. Italy Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 261. Italy Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 262. Italy Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 263. Italy Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 264. Italy Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. Spain Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 266. Spain Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 267. Spain Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 268. Spain Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 269. Spain Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 270. Spain Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 271. Spain Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 272. Spain Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. China Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 274. China Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 275. China Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 276. China Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 277. China Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 278. China Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 279. China Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 280. China Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 281. India Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 282. India Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 283. India Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 284. India Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 285. India Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 286. India Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 287. India Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 288. India Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. Japan Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 290. Japan Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 291. Japan Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 292. Japan Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 293. Japan Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 294. Japan Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 295. Japan Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 296. Japan Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 297. Australia Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 298. Australia Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 299. Australia Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 300. Australia Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 301. Australia Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 302. Australia Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 303. Australia Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 304. Australia Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 305. South Korea Cell Therapy Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 306. South Korea Cell Therapy Manufacturing Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 307. South Korea Cell Therapy Manufacturing Market Size, by Stem Cell Therapies, 2017-2032 (USD Million)
TABLE 308. South Korea Cell Therapy Manufacturing Market Size, by T Cell Therapies, 2017-2032 (USD Million)
TABLE 309. South Korea Cell Therapy Manufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 310. South Korea Cell Therapy Manufacturing Market Size, by Indication, 2017-2032 (USD Million)
TABLE 311. South Korea Cell Therapy Manufacturing Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 312. South Korea Cell Therapy Manufacturing Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. Global Cell Therapy Manufacturing Market Share, by Key Player, 2025
TABLE 314. Global Cell Therapy Manufacturing Market, Key Experts

Companies Mentioned

  • Adaptimmune Therapeutics plc
  • AGC Biologics
  • Allogene Therapeutics Inc
  • Autolus Therapeutics
  • BioNTech SE
  • Bluebird Bio Inc
  • Bristol-Myers Squibb Company
  • Catalent Inc
  • Cellular Biomedicine Group
  • Charles River Laboratories International Inc
  • Fujifilm Diosynth Biotechnologies
  • Gilead Sciences Inc
  • Iovance Biotherapeutics Inc
  • Janssen Biotech Inc
  • Kite Pharma
  • Legend Biotech USA Inc
  • Lonza Group AG
  • Merck KGaA
  • Minaris Advanced Therapies
  • Novartis AG
  • Oxford Biomedica plc
  • Sartorius AG
  • Thermo Fisher Scientific Inc
  • Vertex Pharmaceuticals Incorporated
  • WuXi AppTec

Related Topics

Related Reports

Cell Therapy Technologies Market - Global Forecast 2026-2032 - Product Image

Cell Therapy Technologies Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Cell therapy platform Market - Global Forecast 2026-2032 - Product Image

Cell therapy platform Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Autologous Cell Therapies Market - Global Forecast 2026-2032 - Product Image

Autologous Cell Therapies Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Cellular & Gene Therapy CDMO Market - Global Forecast 2026-2032 - Product Image

Cellular & Gene Therapy CDMO Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Cell Therapy Market - Global Forecast 2026-2032 - Product Image

Cell Therapy Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.